Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement...

Keywords

PrasugrelMedicineClopidogrelThrombolysisCardiologyInternal medicineTiclopidinePlatelet inhibitionClinical trialMyocardial infarction

Affiliated Institutions

Related Publications

2023 ESC Guidelines for the management of acute coronary syndromes

Robert A. Byrne , Xavier Rosselló , J J Coughlan +97 more

peer reviewed

2023 European Heart Journal 3370 citations

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight , Peter Sleight , Sarah Parish +3 more

17,187 patients entering 417 hospitals up to 24 hours (median 5 hours) after the onset of suspected acute myocardial infarction were randomised, with placebo control, between: (...

1988 PubMed 2873 citations

Publication Info

Year: 2006
Type: article
Volume: 152
Issue: 4
Pages: 627-635
Citations: 326
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

326

OpenAlex

Cite This

APA Style

                            
                                
                                    Stephen D. Wiviott, 
                                
                                    Elliott M. Antman, 
                                
                                    C. Michael Gibson
                                
                                et al.
                            
                            (2006). 
                            Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). 
                            American Heart Journal
                            , 152
                            (4)
                            , 627-635.
                            https://doi.org/10.1016/j.ahj.2006.04.012
                        

Identifiers

DOI: 10.1016/j.ahj.2006.04.012